Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Can mHealth improve migrant wellness during public health emergencies? A community-engaged qualitative study during the COVID-19 pandemic.

BMC digital health·2026

Same author

Safety and feasibility of an irrigating external intracranial drain in children.

Journal of neurosurgery. Pediatrics·2026

Same author

Social Determinants of Health and Pediatric Long COVID in the US.

JAMA pediatrics·2026

Same author

Pediatric Pharmacy Association 2025 KIDs List of Key Potentially Inappropriate Drugs in Pediatrics.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2025

Same author

Corrigendum to "Hesitancy and confidence in pediatric COVID-19 vaccination among diverse caregivers of unvaccinated children" [Vaccine 61 (2025) 127245].

Vaccine·2025

Same author

Characterizing Long COVID Symptoms During Early Childhood.

JAMA pediatrics·2025

Search research articles

Related Experiment Video

Updated: Mar 24, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Recent Developments in Pediatric Community-Acquired Pneumonia.

Russell J McCulloh^1,2, Karisma Patel³

¹Division of Infectious Diseases, Children's Mercy Hospital, 2401 Gillham Road, Kansas City, MO, 64108, USA. rmcculloh@cmh.edu.

Current Infectious Disease Reports

|March 11, 2016

Summary

This summary is machine-generated.

This review covers key 2014-2015 findings in pediatric community-acquired pneumonia (CAP), focusing on epidemiology, diagnostics, and treatment. It highlights vaccination

Keywords:

Community-acquired pneumonia Molecular diagnostics Pediatric Pneumococcus Viral pneumonia

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Related Experiment Videos

Last Updated: Mar 24, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Area of Science:

Pediatrics
Infectious Diseases
Public Health

Background:

Community-acquired pneumonia (CAP) is a leading cause of infectious death in children globally.
Research in pediatric CAP encompasses epidemiology, diagnosis, treatment, and prevention.
Significant advancements in understanding and managing pediatric CAP have been reported.

Purpose of the Study:

To review key findings in pediatric CAP research from 2014-2015.
To focus on clinical management aspects of pediatric CAP.
To synthesize recent advances in epidemiology, diagnostics, and treatment.

Main Methods:

Literature review of pediatric CAP research published in 2014-2015.
Focus on significant findings relevant to clinical management.
Categorization of findings into epidemiology, diagnostics, treatment, and policy.

Main Results:

Recent advances in understanding global CAP epidemiology, including the impact of vaccination.
Expanding role of diagnostic technologies for CAP classification and management.
Progress in optimizing antimicrobial use and clinical practice guidelines.

Conclusions:

Vaccination plays a crucial role in preventing pediatric CAP.
Diagnostic technologies are improving CAP classification and management.
Optimized antimicrobial use and updated guidelines enhance clinical management and patient outcomes.